These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3439884)

  • 1. Kinetics of hydrolysis in vitro of nornitrogen mustard, a metabolite of phosphoramide mustard and cyclophosphamide.
    Hemminki K; Alhonen A; Linkola E; Hesso A
    Arch Toxicol; 1987 Dec; 61(2):126-30. PubMed ID: 3439884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
    Hemminki K
    Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of new metabolites of phosphoramide and nor-nitrogen mustards and cyclophosphamide in rat urine using ion cluster techniques.
    Chan KK; Hong SC; Watson E; Deng SK
    Biomed Environ Mass Spectrom; 1986 Mar; 13(3):145-54. PubMed ID: 2938656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-binding products of nornitrogen mustard, a metabolite of cyclophosphamide.
    Hemminki K
    Chem Biol Interact; 1987 Jan; 61(1):75-88. PubMed ID: 3815587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of phosphoramide mustard hydrolysis in aqueous solution.
    Watson E; Dea P; Chan KK
    J Pharm Sci; 1985 Dec; 74(12):1283-92. PubMed ID: 4087195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkylating properties of phosphoramide mustard.
    Colvin M; Brundrett RB; Kan MN; Jardine I; Fenselau C
    Cancer Res; 1976 Mar; 36(3):1121-6. PubMed ID: 1253171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas chromatographic-mass spectrometric assay for N-2-chloroethylaziridine, a volatile cytotoxic metabolite of cyclophosphamide, in rat plasma.
    Lu H; Chan KK
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):219-25. PubMed ID: 8738025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
    Jardine I; Fenselau C; Appler M; Kan MN; Brundrett RB; Colvin M
    Cancer Res; 1978 Feb; 38(2):408-15. PubMed ID: 620410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and mass spectral identification of blood metabolites of cyclophosphamide: evidence for phosphoramide mustard as the biologically active metabolite.
    Struck RF; Kirk MC; Witt MH; Laster WR
    Biomed Mass Spectrom; 1975 Feb; 2(1):46-52. PubMed ID: 1131393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-(2-hydroxyethyl)-N-[2-(7-guaninyl)ethyl]amine, the putative major DNA adduct of cyclophosphamide in vitro and in vivo in the rat.
    Benson AJ; Martin CN; Garner RC
    Biochem Pharmacol; 1988 Aug; 37(15):2979-85. PubMed ID: 3395373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent DNA-Protein Cross-Linking by Phosphoramide Mustard and Nornitrogen Mustard in Human Cells.
    Groehler A; Villalta PW; Campbell C; Tretyakova N
    Chem Res Toxicol; 2016 Feb; 29(2):190-202. PubMed ID: 26692166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy.
    Juma FD; Rogers HJ; Trounce JR
    Br J Clin Pharmacol; 1980 Oct; 10(4):327-35. PubMed ID: 7448105
    [No Abstract]   [Full Text] [Related]  

  • 13. Protonation of phosphoramide mustard and other phosphoramides.
    Gamcsik MP; Ludeman SM; Shulman-Roskes EM; McLennan IJ; Colvin ME; Colvin OM
    J Med Chem; 1993 Nov; 36(23):3636-45. PubMed ID: 8246232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.
    Momerency G; Van Cauwenberghe K; Slee PH; Van Oosterom AT; De Bruijn EA
    Biol Mass Spectrom; 1994 Mar; 23(3):149-58. PubMed ID: 8148406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of cyclophosphamide metabolites by gas chromatography and thermionic specific detection. Interindividual differences in hepatic biotransformation of cyclophosphamide in man in vitro.
    Sessink PJ; Vaes WH; van den Broek PH; Noordhoek J; Bos RP
    J Chromatogr B Biomed Appl; 1995 Nov; 673(2):205-12. PubMed ID: 8611954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat.
    Hong PS; Srigritsanapol A; Chan KK
    Drug Metab Dispos; 1991; 19(1):1-7. PubMed ID: 1673381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half-life of oxazaphosphorines in biological fluids.
    Sladek NE; Powers JF; Grage GM
    Drug Metab Dispos; 1984; 12(5):553-9. PubMed ID: 6149904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to the pharmacokinetics of cyclophosphamide (NSC 26271): Quantitation of metabolites.
    Jardine I; Brundrett R; Colvin M; Fenselau C
    Cancer Treat Rep; 1976 Apr; 60(4):403-8. PubMed ID: 1277214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
    Sladek NE; Doeden D; Powers JF; Krivit W
    Cancer Treat Rep; 1984 Oct; 68(10):1247-54. PubMed ID: 6395951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the metabolism and mode of action of cyclophosphamide.
    Fenselau C
    J Assoc Off Anal Chem; 1976 Sep; 59(5):1028-36. PubMed ID: 965325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.